Patients were identified over a period of 1 year. The presenting symptoms include headache (11 patients), vomiting (6 patients), loss of consciousness (5 patients), focal neurological deficit (3 patients), seizure (3 patients) and neck pain (1 patients). Signs found included papilloedema (4 patients), fever (2 patients), slurring of speech (1 patients) and focal neurological signs (2 patients). The most common underlying condition was dehydration and use of estrogen containing contraceptives. All cases received heparin or LMWH followed by Warfarin. One patient who had CVST associated with pituitary adenoma died. 
IntRoDuctIon

C
erebral venous sinus thrombosis (CVST) is a rare and potentially deadly condition. Known conditions that increase the risk of CVST include hypercoagulable states, dehydration, adjacent infectious processes, low cerebral blood flow, oral contraceptives, hormone replacement therapy, pregnancy, and puerperium. Each of these conditions is associated with a higher risk of venous thrombus formation, but exactly why the cerebral venous sinus system is involved over other veins is unclear (Chaloupka et al.). A specific age group has not been identified as at risk in the literature, and it is not uncommon that a precipitating condition will not be identified (Baker, Opatowsky, Wilson, Glazier, & Morris, 2001; Chaloupka et al.). As the thrombus enlarges, it causes venous congestion and leads to cerebral edema with mass effect and a resultant increase of intracranial pressure. If the thrombus is untreated, the intracranial pressure continues to rise and the vascular supply is compromised, leading to ischemia. This contributes to worsening of neurological status, frequently at an unpredictable and accelerated rate. Complete obstruction of the venous system can occur with exacerbation of cerebral edema, vascular compression, and brain herniation, leading to death. 
MAteRIAlS & MetHoDS
The study is a retrospective study which was carried out at National Neurosurgical Referral center, National Academy of Medical sciences, during the year September 2008 to September 2009(1 Year). Demographic features like age, sex were analyzed.
ReSultS
12
Patients were identified over a period of 1 year. Majority of the patients were from 3rd and 4th decade of their life Table1. There were 7 Females (58%) and (42%) males Table 2 . The presenting symptoms included headache (11 patients), vomiting (6 patients),loss of consciousness(5 patients),focal neurological deficit(3 Patients), seizure(3 Patients) and neck pain (1 patient) Table3. Signs found included papilloedema (4 patient), fever (2 patients), slurring of speech (1 Patient) and focal neurological signs(2 patient) Table4. The most common underlying condition was dehydration and use of estrogen containing contraceptives Table5. The diagnosis was based on CT scan and MRIntra musularRV of the brain. Frequency of Thrombosis of the Major Cerebral Veins and Sinuses was accordingly: Transverse sinus -8 cases; Superior saggital sinus -2 cases ; Straight sinus-2 and in 2 cases multiple sinuses were involved Table 6 .All cases received heparin or LMWH followed by Warfarin. One patient who had CVST associated with pituitary adenoma died.
DIScuSSIon
Cerebral (dural) venous sinus thrombosis is an uncommon condition, but its clinical presentation is varied and often dramatic. It often affects young-tomiddle-aged patients, and more commonly women. Although recognized for more than 100 years, 1 it has only in recent years come to be diagnosed frequently ante-mortem. This is partly due to greater awareness among physicians and neurologists, and partly to improved non-invasive imaging techniques.
We have no reliable data on its incidence, nor on geographical or racial differences in susceptibility.
According to British death certification data from 1952 to 1961, the average mortality from venous sinus thrombosis was 0.4/106/year over this period. 2 Assuming a mortality rate of 10-20% over this period produces an incidence figure of 4-8/106/year, which is likely to be an underestimate.
The superior sagittal and lateral sinuses are commonly (70%) individually involved by thrombosis. In 30%, both are affected, in addition to cortical and cerebellar veins. 3 Cerebral venous sinus thrombosis is more common in particular situations. 85% of patients have at least one of these risk factors 4 Thrombophilia, a tendency to develop blood clots due to abnormalities in coagulation, e.g. factor V Leiden, deficiency of protein C, protein S or antithrombin, or related problems; Nephrotic syndrome, a kidney problem causing protein loss in the urine; Chronic inflammatory diseases, such as inflammatory bowel disease, lupus and Behçet's disease; Pregnancy and puerperium (the period after giving birth); Particular blood disorders, especially polycythemia vera and paroxysmal nocturnal hemoglobinuria; Use of estrogen-containing forms of hormonal contraception; Meningitis and infections of the ear, nose and throat area such as mastoiditis and sinusitis; Direct injury to the venous sinuses and Medical procedures in the head and neck area also can cause thrombosis.
Clinical presentation can be extremely varied, and symptoms can evolve over hours to a few weeks. In a recent Dutch-European study 5 the most frequent symptoms and signs were headache (95%), focal seizures with or without secondary generalization (47%), paresis (uni-or bilateral) (43%) and papilloedema (41%). Fifteen percent were comatose and a further 39% had some impairment of consciousness at presentation. Twenty percent presented with a isolated intracranial hypertension (BIH) type picture (headache, visual disturbance and papilloedema).
The confirmation of a diagnosis of dural venous sinus thrombosis is reliant on demonstration of the thrombus by neuroimaging. Non-invasive imaging by magnetic resonance venography is used in preference to cerebral angiography, 6 although CT contrast venography remains popular in some centres, and may be a superior technique in certain cases. 7 The 'typical' empty delta sign seen on contrast CT scanning is present, however, only in 20% of cases. 8 This is seen on axial CT images, and represents enhancement with i.v contrast of the wall of the posterior sagittal sinus, outlining the clot within the lumen anteriorly. In most centres however, MRI/V is usually the investigation of choice for demonstrating dural sinus thrombosis, as it may exclude significant alternative diagnoses and will also demonstrate cerebral venous infarction complicating cerebral venous occlusion. Difficulties in diagnosis arise due to unusual normal anatomical variants and cases where there is near-occlusion of the venous sinus. 9 Treatment is basically nonoperatively. Clinical practice guidelines now recommend heparin or low molecular weight heparin in the initial treatment, followed by warfarin, provided there are no other bleeding risks that would make these treatments unsuitable. 10, 11, 12 Some experts discourage the use of anticoagulation if there is extensive hemorrhage; in that case, they recommend repeating the imaging after 7-10 days. If the hemorrhage has decreased in size, anticoagants are commenced, while no anticoagulants are given if there is no reduction. 13 The duration of warfarin treatment depends on the circumstances and underlying causes of the condition. If the thrombosis developed under temporary circumstances (e.g. pregnancy), three months are regarded as sufficient. If the condition was unprovoked but there are no clear causes or a "mild" form of thrombophilia, 6 to 12 months is advised. If there is a severe underlying thrombosis disorder, warfarin treatment may need to continue indefinitely.
14 Thrombolysis (removal of the blood clot with "clot buster" medication) has been described, either systemically by injection into a vein or directly into the clot during angiography. The 2006 European Federation of Neurological Societies guideline recommends that thrombolysis is only used in patients who deteriorate despite adequate treatment, and other causes of deterioration have been eliminated. It is unclear which drug and which mode of administration is the most effective. Bleeding into the brain and in other sites of the body is a major concern in the use of thrombolysis. 15 American guidelines make no recommendation with regards to thrombolysis, stating that more research is needed. 16 Raised intracranial pressure, if severe or threatening vision, may require therapeutic lumbar puncture (removal of excessive cerebrospinal fluid), medication (acetazolamide), or neurosurgical treatment (optic nerve sheath fenestration or shunting). 17 In certain situations, anticonvulsants may be used to prevent seizures; these are focal neurological problems (e.g. inability to move a limb) and/or focal changes of the brain tissue on CT or MRI scan. 
ReFeRenceS
